Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up

Author: Yalcin Arzu Didem   Uçar Seçil   Gumuslu Saadet   Strauss Ludwig G.  

Publisher: Informa Healthcare

ISSN: 0892-3973

Source: Immunopharmacology and Immunotoxicology, Vol.35, Iss.4, 2013-08, pp. : 524-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content